{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:22:21Z","timestamp":1790173341654,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T00:00:00Z","timestamp":1413849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00384-014-2029-1","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T04:39:28Z","timestamp":1413952768000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Advances in malignant peritoneal mesothelioma"],"prefix":"10.1007","volume":"30","author":[{"given":"Shoubo","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehai","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,21]]},"reference":[{"key":"2029_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gcb.2010.07.016","volume":"35","author":"H Sharma","year":"2011","unstructured":"Sharma H, Bell I, Schofield J et al (2011) Primary peritoneal mesothelioma: case series and literature review. Clin Res Hepathol Gastroenterol 35:55\u201359","journal-title":"Clin Res Hepathol Gastroenterol"},{"key":"2029_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ly BH, Dodson RF et al (2012) Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 227:44\u201358","journal-title":"J Cell Physiol"},{"key":"2029_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-3-34","volume":"3","author":"AJ Moore","year":"2008","unstructured":"Moore AJ, Parker RJ, Wiggins J (2008) Malignant mesothelioma. Orphanet J Rare Dis 3:34","journal-title":"Orphanet J Rare Dis"},{"key":"2029_CR4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353:1591\u20131603","journal-title":"N Engl J Med"},{"key":"2029_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lungcan.2007.12.025","volume":"61","author":"OD Roe","year":"2008","unstructured":"Roe OD, Creaney J, Lundgren S et al (2008) Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case\u2013control study. Lung Cancer 61:235\u2013243","journal-title":"Lung Cancer"},{"key":"2029_CR6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejso.2006.03.009","volume":"32","author":"R Garcia-Carbonero","year":"2006","unstructured":"Garcia-Carbonero R, Paz-Ares L (2006) Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol 32:676\u2013681","journal-title":"Eur J Surg Oncol"},{"key":"2029_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/030089160509100101","volume":"91","author":"V Pangher Manzini De","year":"2005","unstructured":"De Pangher Manzini V (2005) Malignant peritoneal mesothelioma. Tumori 91:1\u20135","journal-title":"Tumori"},{"key":"2029_CR8","first-page":"260","volume":"17","author":"JC Wagner","year":"1960","unstructured":"Wagner JC, Sleegs CA, Marchand P (1960) Diffuse pleural mesothelioma. Br J Ind Med 17:260\u2013271","journal-title":"Br J Ind Med"},{"key":"2029_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.47102\/annals-acadmedsg.V42N6p291","volume":"42","author":"GH Tan","year":"2013","unstructured":"Tan GH, Cheung M, Chanyaputhipong J et al (2013) Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma. Ann Acad Med Singapore 42:291\u2013296","journal-title":"Ann Acad Med Singapore"},{"key":"2029_CR10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ctrv.2011.10.006","volume":"38","author":"P Mirarabshahii","year":"2012","unstructured":"Mirarabshahii P, Pillai K, Chua TC et al (2012) Diffuse malignant peritoneal mesothelioma\u2014an update on treatment. Cancer Treat Rev 38:605\u2013612","journal-title":"Cancer Treat Rev"},{"key":"2029_CR11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magge","year":"2014","unstructured":"Magge D, Zenati MS, Austin F et al (2014) Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol 21:1159\u20131165","journal-title":"Ann Surg Oncol"},{"key":"2029_CR12","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"49","author":"D Baratti","year":"2013","unstructured":"Baratti D, Kusamura S, Cabras AD et al (2013) Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer 49:3140\u20133148","journal-title":"Eur J Cancer"},{"key":"2029_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.21177","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Morris DL (2009) Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol 99:109\u2013113","journal-title":"J Surg Oncol"},{"key":"2029_CR14","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237\u20136242","journal-title":"J Clin Oncol"},{"key":"2029_CR15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjsurg.2011.09.009","volume":"203","author":"B Goslin","year":"2012","unstructured":"Goslin B, Sevak S, Siripong A et al (2012) Outcomes of cytoreduction with hyperthermic intraperitoneal chemotherapy: our experience at a midwest community hospital. Am J Surg 203:383\u2013386","journal-title":"Am J Surg"},{"key":"2029_CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700120212","volume":"12","author":"J Miller","year":"1908","unstructured":"Miller J, Wynn H (1908) A malignant tumor arising from the endothelium of the peritoneum and producing a mucoid ascitic fluid. J Pathol Bacteriol 12:267","journal-title":"J Pathol Bacteriol"},{"key":"2029_CR17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.20820","volume":"115","author":"A Marinaccio","year":"2005","unstructured":"Marinaccio A, Montanaro F, Mastrantonio M et al (2005) Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer 115:142\u2013147","journal-title":"Int J Cancer"},{"key":"2029_CR18","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1742-1241.2007.01334.x","volume":"63","author":"E Gogou","year":"2009","unstructured":"Gogou E, Kerenidi T, Chamos V et al (2009) Mesothelioma mortality in Greece from 1983 to 2003. Int J Clin Pract 63:944\u2013948","journal-title":"Int J Clin Pract"},{"key":"2029_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2486\/indhealth.MS1184","volume":"50","author":"T Myojin","year":"2012","unstructured":"Myojin T, Azuma K, Okumura J et al (2012) Future trends of mesothelioma mortality in Japan based on a risk function. Ind Health 50:197\u2013204","journal-title":"Ind Health"},{"key":"2029_CR20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10552-014-0368-4","volume":"25","author":"SJ Schonfeld","year":"2014","unstructured":"Schonfeld SJ, McCormack V, Rutherford MJ et al (2014) Regional variations in German mesothelioma mortality rates: 2000\u20132010. Cancer Causes Control 25:615\u2013624","journal-title":"Cancer Causes Control"},{"key":"2029_CR21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","volume":"92","author":"JT Hodgson","year":"2005","unstructured":"Hodgson JT, McElvenny DM, Darnton AJ et al (2005) The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 92:587\u2013593","journal-title":"Br J Cancer"},{"key":"2029_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/oem.2007.034769","volume":"65","author":"S Pitarque","year":"2008","unstructured":"Pitarque S, Cl\u00e8ries R, Mart\u00ednez JM et al (2008) Mesothelioma mortality in men: trends during 1977\u20132001 and projections for 2002\u20132016 in Spain. Occup Environ Med 65:279\u2013282","journal-title":"Occup Environ Med"},{"key":"2029_CR23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/oem.57.7.488","volume":"57","author":"A Banaei","year":"2000","unstructured":"Banaei A, Auvert B, Goldberg M et al (2000) Future trends in mortality of French men from mesothelioma. Occup Environ Med 57:488\u2013494","journal-title":"Occup Environ Med"},{"key":"2029_CR24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajim.10047","volume":"41","author":"J Leigh","year":"2002","unstructured":"Leigh J, Davidson P, Hendrie L et al (2002) Malignant mesothelioma in Australia, 1945\u20132000. Am J Ind Med 41:188\u2013201","journal-title":"Am J Ind Med"},{"key":"2029_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/aje\/kwh025","volume":"159","author":"B Price","year":"2004","unstructured":"Price B, Ware A (2004) Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 159:107\u2013112","journal-title":"Am J Epidemiol"},{"key":"2029_CR26","first-page":"1","volume":"30","author":"H Naka","year":"1984","unstructured":"Naka H, Naka A (1984) Clinicopathological study on 100 Japanese patients with peritoneal mesothelioma in Japan. Gan No Rinsho 30:1\u201310","journal-title":"Gan No Rinsho"},{"key":"2029_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.99.13352399","volume":"13","author":"M Metintas","year":"1999","unstructured":"Metintas M, Hillerdal G, Metintas S (1999) Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort. Eur Respir J 13:523\u2013526","journal-title":"Eur Respir J"},{"key":"2029_CR28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00000421-199508000-00009","volume":"18","author":"C Stey","year":"1995","unstructured":"Stey C, Landolt-Weber U, Vetter W et al (1995) Malignant peritoneal mesothelioma after Thorotrast exposure. Am J Clin Oncol 18:313\u2013317","journal-title":"Am J Clin Oncol"},{"key":"2029_CR29","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.1996.14.7.2098","volume":"14","author":"LB Weissmann","year":"1996","unstructured":"Weissmann LB, Corson JM, Neugut AI et al (1996) Malignant mesothelioma following treatment for Hodgkin\u2019s disease. J Clin Oncol 14:2098\u20132100","journal-title":"J Clin Oncol"},{"key":"2029_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1097-4644(20000201)76:2<181::AID-JCB2>3.0.CO;2-9","volume":"76","author":"N Shivapurkar","year":"1999","unstructured":"Shivapurkar N, Wiethege T, Wistuba II et al (1999) Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 76:181\u2013188","journal-title":"J Cell Biochem"},{"key":"2029_CR31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/030089160308900307","volume":"89","author":"YI Acherman","year":"2003","unstructured":"Acherman YI, Welch LS, Bromley CM et al (2003) Clinical presentation of peritoneal mesothelioma. Tumori 89:269\u2013273","journal-title":"Tumori"},{"key":"2029_CR32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","volume":"21","author":"P Manzini Vde","year":"2010","unstructured":"Manzini Vde P, Recchia L, Cafferata M et al (2010) Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol 21:348\u2013353","journal-title":"Ann Oncol"},{"key":"2029_CR33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00384-014-1875-1","volume":"29","author":"SB Cao","year":"2014","unstructured":"Cao SB, Jin S, Cao JY et al (2014) Colonic invasion induced by malignant peritoneal mesothelioma. Int J Colorectal Dis 29:891\u2013892","journal-title":"Int J Colorectal Dis"},{"key":"2029_CR34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4240\/wjgs.v1.i1.38","volume":"1","author":"S Munkholm-Larsen","year":"2009","unstructured":"Munkholm-Larsen S, Cao CQ, Yan TD (2009) Malignant peritoneal mesothelioma. World J Gastrointest Surg 1:38\u201348","journal-title":"World J Gastrointest Surg"},{"key":"2029_CR35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/MCG.0b013e318297fa65","volume":"47","author":"C Tabata","year":"2013","unstructured":"Tabata C, Kanemura S, Tabata R et al (2013) Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma. J Clin Gastroenterol 47:684\u2013688","journal-title":"J Clin Gastroenterol"},{"key":"2029_CR36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2214\/AJR.07.3628","volume":"191","author":"JY Park","year":"2008","unstructured":"Park JY, Kim KW, Kwon HJ et al (2008) Peritoneal mesotheliomas: clinicopathologic features, CT findings, and differential diagnosis. AJR Am J Roentgenol 191:814\u2013825","journal-title":"AJR Am J Roentgenol"},{"key":"2029_CR37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.prp.2011.04.004","volume":"207","author":"S Nagata","year":"2011","unstructured":"Nagata S, Tomoeda M, Kubo C et al (2011) Malignant mesothelioma of the peritoneum invading the liver and mimicking metastatic carcinoma: a case report. Pathol Res Pract 207:395\u2013398","journal-title":"Pathol Res Pract"},{"key":"2029_CR38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s003300051010","volume":"10","author":"M Daskalogiannaki","year":"2000","unstructured":"Daskalogiannaki M, Prassopoulos P, Raissaki M et al (2000) Malignant peritoneal mesothelioma presenting with respiratory symptoms. Eur Radiol 10:814\u2013816","journal-title":"Eur Radiol"},{"key":"2029_CR39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2559.2004.01865.x","volume":"45","author":"MK Heatley","year":"2004","unstructured":"Heatley MK (2004) Sister Mary Joseph\u2019s nodule in malignant mesothelioma. Histopathology 45:299\u2013300","journal-title":"Histopathology"},{"key":"2029_CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002470050732","volume":"30","author":"M Haliloglu","year":"2000","unstructured":"Haliloglu M, Hoffer FA, Fletcher BD (2000) Malignant peritoneal mesothelioma in two pediatric patients: MR imaging findings. Pediatr Radiol 30:251\u2013255","journal-title":"Pediatr Radiol"},{"key":"2029_CR41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejrad.2007.08.010","volume":"64","author":"M Yamamuro","year":"2007","unstructured":"Yamamuro M, Gerbaudo VH, Gill RR et al (2007) Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol 64:356\u2013366","journal-title":"Eur J Radiol"},{"key":"2029_CR42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/RLU.0b013e3182478bb5","volume":"37","author":"Q Cao","year":"2012","unstructured":"Cao Q, Lu M, Heath J et al (2012) 18F-FDG PET\/CT in a recurrent diffuse malignant peritoneal mesothelioma. Clin Nucl Med 37:492\u2013494","journal-title":"Clin Nucl Med"},{"key":"2029_CR43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/bjs.8908","volume":"100","author":"LH Iversen","year":"2013","unstructured":"Iversen LH, Rasmussen PC, Laurberg S (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285\u2013292","journal-title":"Br J Surg"},{"key":"2029_CR44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1477-7819-11-251","volume":"11","author":"J Wang","year":"2013","unstructured":"Wang J, Gao L, Tang S et al (2013) A retrospective analysis on the diagnostic value of ultrasound-guided percutaneous biopsy for peritoneal lesions. World J Surg Oncol 11:251","journal-title":"World J Surg Oncol"},{"key":"2029_CR45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5858\/2008-132-397-AOITTD","volume":"132","author":"AM Marchevsky","year":"2008","unstructured":"Marchevsky AM (2008) Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med 132:397\u2013401","journal-title":"Arch Pathol Lab Med"},{"key":"2029_CR46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.pap.0000213064.05005.64","volume":"13","author":"S Suster","year":"2006","unstructured":"Suster S, Moran CA (2006) Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol 13:316\u2013329","journal-title":"Adv Anat Pathol"},{"key":"2029_CR47","first-page":"472","volume":"5","author":"S Ta\u015fk\u0131n","year":"2012","unstructured":"Ta\u015fk\u0131n S, G\u00fcm\u00fc\u015f Y, Kiremit\u00e7i S et al (2012) Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series and review of the clinical and immunohistochemical features. Int J Clin Exp Pathol 5:472\u2013478","journal-title":"Int J Clin Exp Pathol"},{"key":"2029_CR48","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","volume":"34","author":"AR Laury","year":"2010","unstructured":"Laury AR, Hornick JL, Perets R et al (2010) PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol 34:627\u2013635","journal-title":"Am J Surg Pathol"},{"key":"2029_CR49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s004040100189","volume":"266","author":"P Krasuski","year":"2002","unstructured":"Krasuski P, Poniecka A, Gal E (2002) The diagnostic challenge of peritoneal mesothelioma. Arch Gynecol Obstet 266:130\u2013132","journal-title":"Arch Gynecol Obstet"},{"key":"2029_CR50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1631\/jzus.B1000338","volume":"12","author":"LY Chen","year":"2011","unstructured":"Chen LY, Huang LX, Wang J et al (2011) Malignant peritoneal mesothelioma presenting with persistent high fever. J Zhejiang Univ Sci B 12:381\u2013384","journal-title":"J Zhejiang Univ Sci B"},{"key":"2029_CR51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/1097-0142(197309)32:3<656::AID-CNCR2820320319>3.0.CO;2-U","volume":"32","author":"EE Rogoff","year":"1973","unstructured":"Rogoff EE, Hilaris BS, Huvos AG (1973) Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation. Cancer 32:656\u2013664","journal-title":"Cancer"},{"key":"2029_CR52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-8258(83)90101-4","volume":"16","author":"J Cain","year":"1983","unstructured":"Cain J, Nori D, Huvos A et al (1983) The role of radioactive colloids in malignant peritoneal mesothelioma. Gynecol Oncol 16:263\u2013274","journal-title":"Gynecol Oncol"},{"key":"2029_CR53","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19870601)59:11<1882::AID-CNCR2820591107>3.0.CO;2-0","volume":"59","author":"GS Lederman","year":"1987","unstructured":"Lederman GS, Recht A, Herman T et al (1987) Long-term survival in peritoneal mesothelioma. The role of radiotherapy and combined modality treatment. Cancer 59:1882\u20131886","journal-title":"Cancer"},{"key":"2029_CR54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COC.0b013e3180684181","volume":"31","author":"ME Hesdorffer","year":"2008","unstructured":"Hesdorffer ME, Chabot JA, Keohan ML et al (2008) Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma. Am J Clin Oncol 31:49\u201354","journal-title":"Am J Clin Oncol"},{"key":"2029_CR55","first-page":"322","volume":"28","author":"K Takeuchi","year":"2007","unstructured":"Takeuchi K, Fujimoto M, Tsujino T et al (2007) Impressive remission of locally advanced malignant peritoneal mesothelioma treated with combination of radiotherapy and intraperitoneal paclitaxel. Eur J Gynaecol Oncol 28:322\u2013323","journal-title":"Eur J Gynaecol Oncol"},{"key":"2029_CR56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6004\/jnccn.2012.0008","volume":"10","author":"K Turner","year":"2012","unstructured":"Turner K, Varghese S, Alexander HR Jr (2012) Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma. J Natl Compr Cancer Netw 10:49\u201357","journal-title":"J Natl Compr Cancer Netw"},{"key":"2029_CR57","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/annonc\/mdj073","volume":"17","author":"ME O\u2019Brien","year":"2006","unstructured":"O\u2019Brien ME, Watkins D, Ryan C et al (2006) A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial. Ann Oncol 17:270\u2013275","journal-title":"Ann Oncol"},{"key":"2029_CR58","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","volume":"26","author":"GR Simon","year":"2008","unstructured":"Simon GR, Verschraegen CF, J\u00e4nne PA et al (2008) Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol 26:3567\u20133572","journal-title":"J Clin Oncol"},{"key":"2029_CR59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11864-001-0043-3","volume":"2","author":"CF Verschraegen","year":"2001","unstructured":"Verschraegen CF (2001) Intracavitary therapies for mesothelioma. Curr Treat Options Oncol 2:385\u2013394","journal-title":"Curr Treat Options Oncol"},{"key":"2029_CR60","doi-asserted-by":"crossref","first-page":"S553","DOI":"10.1245\/s10434-013-2976-8","volume":"20","author":"JC Leinwand","year":"2013","unstructured":"Leinwand JC, Zhao B, Guo X et al (2013) Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy. Ann Surg Oncol 20:S553\u2013S559","journal-title":"Ann Surg Oncol"},{"key":"2029_CR61","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jtcvs.2012.10.042","volume":"145","author":"RB Cameron","year":"2013","unstructured":"Cameron RB, Hou D (2013) Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation. J Thorac Cardiovasc Surg 145:496\u2013504","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2029_CR62","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2000.01571.x","volume":"87","author":"G Sebbag","year":"2000","unstructured":"Sebbag G, Yan H, Shmookler BM et al (2000) Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87:1587\u20131593","journal-title":"Br J Surg"},{"key":"2029_CR63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco M, Nonaka D, Baratti D et al (2006) Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 13:229\u2013237","journal-title":"Ann Surg Oncol"},{"key":"2029_CR64","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1245\/s10434-013-2947-0","volume":"20","author":"MC Teo","year":"2013","unstructured":"Teo MC, Tan GH, Tham CK et al (2013) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Ann Surg Oncol 20:2968\u20132974","journal-title":"Ann Surg Oncol"},{"key":"2029_CR65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander Jr","year":"2013","unstructured":"Alexander HR Jr, Bartlett DL, Pingpank JF et al (2013) Treatment factors associated with long-term survival following cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery 153:779\u2013786","journal-title":"Surgery"},{"key":"2029_CR66","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cam4.80","volume":"2","author":"M Haslinger","year":"2013","unstructured":"Haslinger M, Francescutti V, Attwood K et al (2013) A contemporary analysis of morbidity and outcomes in cytoreduction\/hyperthermic intraperitoneal chemoperfusion. Cancer Med 2:334\u2013342","journal-title":"Cancer Med"},{"key":"2029_CR67","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"EA Levine","year":"2014","unstructured":"Levine EA, Stewart JH 4th, Shen P et al (2014) Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg 218:573\u2013587","journal-title":"J Am Coll Surg"},{"key":"2029_CR68","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF et al (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21:4560\u20134567","journal-title":"J Clin Oncol"},{"key":"2029_CR69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1245\/s10434-009-0763-3","volume":"17","author":"HR Alexander Jr","year":"2010","unstructured":"Alexander HR Jr (2010) Surgical treatment of malignant peritoneal mesothelioma: past, present, and future. Ann Surg Oncol 17:21\u201322","journal-title":"Ann Surg Oncol"},{"key":"2029_CR70","first-page":"1252","volume":"52","author":"G Los","year":"1992","unstructured":"Los G, Smals OA, van Vugt MJ et al (1992) A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res 52:1252\u20131258","journal-title":"Cancer Res"},{"key":"2029_CR71","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-013-3224-y","volume":"21","author":"RW Randle","year":"2014","unstructured":"Randle RW, Swett KR, Swords DS et al (2014) Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol 21:1474\u20131479","journal-title":"Ann Surg Oncol"},{"key":"2029_CR72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","volume":"215","author":"KI Votanopoulos","year":"2012","unstructured":"Votanopoulos KI, Ihemelandu C, Shen P et al (2012) Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg 215:412\u2013417","journal-title":"J Am Coll Surg"},{"key":"2029_CR73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jso.23356","volume":"108","author":"TC Chua","year":"2013","unstructured":"Chua TC, Quinn LE, Zhao J et al (2013) Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. J Surg Oncol 108:81\u201388","journal-title":"J Surg Oncol"},{"key":"2029_CR74","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1200\/JCO.1996.14.3.878","volume":"14","author":"P Souli\u00e9","year":"1996","unstructured":"Souli\u00e9 P, Ruffi\u00e9 P, Trandafir L et al (1996) Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin\/interferon alfa-2a. J Clin Oncol 14:878\u2013885","journal-title":"J Clin Oncol"},{"key":"2029_CR75","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01519898","volume":"40","author":"H Bielefeldt-Ohmann","year":"1995","unstructured":"Bielefeldt-Ohmann H, Marzo AL, Himbeck RP et al (1995) Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy. Cancer Immunol Immunother 40:241\u2013250","journal-title":"Cancer Immunol Immunother"},{"key":"2029_CR76","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s005950050200","volume":"28","author":"M Tani","year":"1998","unstructured":"Tani M, Tanimura H, Yamaue H et al (1998) Successful immunochemotherapy for patients with malignant mesothelioma: report of two cases. Surg Today 28:647\u2013651","journal-title":"Surg Today"},{"key":"2029_CR77","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.200501-057OC","volume":"171","author":"JP Hegmans","year":"2005","unstructured":"Hegmans JP, Hemmes A, Aerts JG et al (2005) Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells. Am J Respir Crit Care Med 171:1168\u20131177","journal-title":"Am J Respir Crit Care Med"},{"key":"2029_CR78","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/ijc.25557","volume":"128","author":"M Ho","year":"2011","unstructured":"Ho M, Feng M, Fisher RJ et al (2011) A novel high-affinity human monoclonal antibody to mesothelin. Int J Cancer 128:2020\u20132030","journal-title":"Int J Cancer"},{"key":"2029_CR79","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","volume":"11","author":"R Govindan","year":"2005","unstructured":"Govindan R, Kratzke RA, Herndon JE 2nd et al (2005) Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Clin Cancer Res 11:2300\u20132304","journal-title":"Clin Cancer Res"},{"key":"2029_CR80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Brun EA, Cerruto CA et al (2007) Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 14:41\u201349","journal-title":"Ann Surg Oncol"},{"key":"2029_CR81","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/annonc\/mdr477","volume":"23","author":"C Cao","year":"2012","unstructured":"Cao C, Yan TD, Deraco M et al (2012) Importance of gender in diffuse malignant peritoneal mesothelioma. Ann Oncol 23:1494\u20131498","journal-title":"Ann Oncol"},{"key":"2029_CR82","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.athoracsur.2010.04.110","volume":"90","author":"AS Wolf","year":"2010","unstructured":"Wolf AS, Richards WG, Tilleman TR et al (2010) Characteristics of malignant pleural mesothelioma in women. Ann Thorac Surg 90:949\u2013956","journal-title":"Ann Thorac Surg"},{"key":"2029_CR83","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00432-013-1408-2","volume":"139","author":"K Pillai","year":"2013","unstructured":"Pillai K, Pourgholami MH, Chua TC et al (2013) Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 139:987\u2013994","journal-title":"J Cancer Res Clin Oncol"},{"key":"2029_CR84","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2006.05.009","volume":"32","author":"TD Yan","year":"2006","unstructured":"Yan TD, Yoo D, Sugarbaker PH (2006) Significance of lymph node metastasis in patients with malignant peritoneal mesothelioma. Eur J Surg Oncol 32:948\u2013953","journal-title":"Eur J Surg Oncol"},{"key":"2029_CR85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","volume":"17","author":"D Baratti","year":"2010","unstructured":"Baratti D, Kusamura S, Cabras AD et al (2010) Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 17:45\u201353","journal-title":"Ann Surg Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-014-2029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-014-2029-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-014-2029-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T12:51:58Z","timestamp":1689598318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-014-2029-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,21]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2029"],"URL":"https:\/\/doi.org\/10.1007\/s00384-014-2029-1","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,21]]}}}